Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...

Discover expert-relief solutions for managing atopic dermatitis, from breakthrough treatments to daily habits that prevent ...

Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.

Learn how ultrafine bubble showers can improve eczema symptoms by reducing inflammation and enhancing skin barrier proteins.

Perioral dermatitis is a red, bumpy rash that affects the skin around your mouth. The condition is most common in females between 20 and 45 Causes include topical steroid creams, corticosteroid ...

A person can use zinc oxide creams and ointments to apply directly to the skin. Some research has linked eczema, also known as atopic dermatitis, to zinc deficiency. However, this research is ...

Panelists discuss how ruxolitinib cream demonstrated significant clinical efficacy in treating atopic dermatitis over a 12-month period, with claims analysis revealing improved disease control, ...

Red itchy skin Understand the difference between atopic dermatitis linked to allergies and general eczema with this ...

Arcutis shares traded higher on Monday after Health Canada approved its Zoryve cream for the treatment of mild to moderate atopic dermatitis.

Data demonstrated favorable safety and local tolerability of ZORYVE ® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) with prior inadequate response, intolerance ...